Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orencia in refractory non-infectious uveitis
NCT01279954Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jan 2012
- Primary completion
- Jun 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in noninfectious uveitis (NIU), sponsored by Oregon Health & Science University. Started Jan 2012; status: completed.
02
Drugs
abatacept
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT01279954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01279954.